Screener
Corvus Pharmaceuticals CRVS Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-057100
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 15) | ||
| Stockholders’ equity: | ||
| Preferred stock: $0.0001 par value; 10,000,000 shares authorized at March 31, 2026 and December 31, 2025; 0 shares issued and outstanding at each of March 31, 2026 and December 31, 2025 | — | — |
| Common stock: $0.0001 par value; 290,000,000 shares authorized at March 31, 2026 and December 31, 2025; 84,090,424 and 74,696,629 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 8 | 7 |
| Additional paid-in capital | 667,782 | 474,387 |
| Accumulated other comprehensive loss | (1,126) | (896) |
| Accumulated deficit | (425,985) | (412,293) |
| Total stockholders’ equity | 240,679 | 61,205 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Corvus Pharmaceuticals's common stock?
- Corvus Pharmaceuticals (CRVS) reported common stock of $8K in Q1 2026.
- How has Corvus Pharmaceuticals's common stock changed year-over-year?
- Corvus Pharmaceuticals's common stock increased by 14.3% year-over-year, from $7K to $8K.
- What is the long-term trend for Corvus Pharmaceuticals's common stock?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's common stock has grown at a 18.5% compound annual growth rate (CAGR), from $3K to $7K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Corvus Pharmaceuticals's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude